Neuromonics Receives Contract from U.S. Army to Study Treatment

Neuromonics, Inc., the maker and distributor of the Oasis, an FDA-cleared, patented and clinically proven medical device designed for long-term significant relief of tinnitus, has received a $700,000 contract from the U.S. Army to study the effects and use of the Neuromonics Tinnitus Treatment (NTT) in military environments. The clinical study is examining the effects of placebo treatment and the NTT in active and retired members of the military with tinnitus.